Lonza · 2 weeks ago
QA Specialist V - QA Inspection Audit Management
Lonza is a global leader in life sciences, dedicated to manufacturing the medicines of tomorrow. The QA Specialist V will play a crucial role in ensuring compliance and excellence in internal audits, customer audits, and regulatory inspections, while maintaining high standards in GMP and quality culture.
BiotechnologyLife SciencePharmaceutical
Responsibilities
Lead or support internal audits, including planning, execution, and reporting
Prepare and manage activities for customer audits and regulatory inspections
Act as host or back-room manager during audits and inspections
Coach subject matter experts on audit interactions and compliance expectations
Ensure timely closure of quality system records and escalate compliance risks when needed
Mentor and train other QA Specialists in audit and inspection processes
Apply data integrity principles and maintain GMP compliance in all activities
Qualification
Required
Bachelor's degree in a scientific or technical field (or equivalent experience)
10+ years of experience in GMP environments and quality assurance
Strong knowledge of FDA, EMA, and ICH regulations
Direct experience with regulatory inspections and customer audits
Excellent communication and presentation skills
Ability to lead in high-pressure situations and manage multiple priorities
Preferred
Certified Quality Auditor (CQA) preferred
Benefits
Medical, dental, and vision insurance.
Company
Lonza
Lonza Group supplies products and services to pharmaceutical and agrochemical industries.
H1B Sponsorship
Lonza has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2024 (3)
2022 (1)
2021 (3)
2020 (2)
Funding
Current Stage
Public CompanyTotal Funding
$444.8M2023-11-06Post Ipo Debt· $444.8M
2020-12-07IPO
Recent News
2026-01-07
2026-01-05
Company data provided by crunchbase